149 Bio None
Company 149 Bio is working on a drug discovery platform for treating kidney disease, GI diseases, fibrosis, and autoimmune diseases by developing targeted therapies against integrin receptors.
Company 149 Bio is working on a drug discovery platform for treating kidney disease, GI diseases, fibrosis, and autoimmune diseases by developing targeted therapies against integrin receptors.